Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore

Journal of Medicinal Chemistry

Volumn 42, Issue 9, 1999, Pages 1501-1504

  Endo, Yasuyuki ^a   Iijima, Toru ^a   Yamakoshi, Yuko ^a   Yamaguchi, Mitsuhiro ^a   Fukasawa, Hiroshi ^a   Shudo, Koichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CARBORANE DERIVATIVE; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; STILBENE DERIVATIVE; TAMOXIFEN;

ANIMAL CELL; ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; LIGAND BINDING; MOLECULAR STABILITY; MONKEY; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BORANES; COS CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; RATS; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0033529016     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9900725     Document Type: Article

References (24)

1. 12 and their derivatives. Chem. Rev. 1992, 92, 209-223.
2. For a recent review, see: Plesek, J. Potential application of boron cluster compounds. Chem. Rev. 1992, 92, 269-286.
3. For a recent review, see: Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F.-G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. The chemistry of neutron capture therapy. Chem. Rev. 1998, 98, 1515-1562.
4. Yamamoto, Y.; Seko, T.; Nakamura, H.; Nemoto, H.; Hojo, H.; Nukai, N.; Hashimoto, Y. Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells. J. Chem. Soc., Chem. Commun. 1992, 157-158. Tjarks, W.; Anisuzzaman, A. K. M.; Liu, L.; Soloway, A. H.; Barth, R. F.; Perkins, D. J.; Adams, D. M. Synthesis and in vitro evaluation of boronated undine and glucose derivatives for boron neutron capture therapy. J. Med. Chem. 1992, 35, 1628-1633.
5. Yamamoto, Y.; Seko, T.; Nakamura, H.; Nemoto, H.; Hojo, H.; Nukai, N.; Hashimoto, Y. Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells. J. Chem. Soc., Chem. Commun. 1992, 157-158. Tjarks, W.; Anisuzzaman, A. K. M.; Liu, L.; Soloway, A. H.; Barth, R. F.; Perkins, D. J.; Adams, D. M. Synthesis and in vitro evaluation of boronated undine and glucose derivatives for boron neutron capture therapy. J. Med. Chem. 1992, 35, 1628-1633.
6. Leukart, O.; Caviezel, M.; Eberle, A.; Escher, E.; Tun-Kyi, A.; Schwyzer, R. L-Carboranylalanine, a boron analogue of phenylalanine. Helv. Chim. Acta 1976, 59, 2184-2187. Wyzlic, I. M.; Soloway, A. H. A general, convenient way to carborane-containing amino acids for boron neutron capture therapy. Tetrahedron Lett. 1993, 33, 7489-7492. Radel, P. A.; Kahl, A. B.; Enantio-selective synthesis of L- and D-carboranylalanine. J. Org. Chem. 1996, 61, 4582-4588.
7. Leukart, O.; Caviezel, M.; Eberle, A.; Escher, E.; Tun-Kyi, A.; Schwyzer, R. L-Carboranylalanine, a boron analogue of phenylalanine. Helv. Chim. Acta 1976, 59, 2184-2187. Wyzlic, I. M.; Soloway, A. H. A general, convenient way to carborane-containing amino acids for boron neutron capture therapy. Tetrahedron Lett. 1993, 33, 7489-7492. Radel, P. A.; Kahl, A. B.; Enantio-selective synthesis of L- and D-carboranylalanine. J. Org. Chem. 1996, 61, 4582-4588.
8. Leukart, O.; Caviezel, M.; Eberle, A.; Escher, E.; Tun-Kyi, A.; Schwyzer, R. L-Carboranylalanine, a boron analogue of phenylalanine. Helv. Chim. Acta 1976, 59, 2184-2187. Wyzlic, I. M.; Soloway, A. H. A general, convenient way to carborane-containing amino acids for boron neutron capture therapy. Tetrahedron Lett. 1993, 33, 7489-7492. Radel, P. A.; Kahl, A. B.; Enantio-selective synthesis of L- and D-carboranylalanine. J. Org. Chem. 1996, 61, 4582-4588.
9. Iijima, T.; Endo, Y.; Tsuji, M.; Kawachi, E.; Kagechika, H.; Shudo, K. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists. Chem. Pharm. Bull. 1999, 47, 398-404. Endo, Y.; Iijima, T.; Ohta, K.; Kagechika, H.; Kawachi, E.; Shudo, K Dicarba-closo-dodecaboranes as a Pharmacophore. Nonel Potent Retinoidal Agonists. Chem. Pharm. Bull. 1999, 47, 585-587.
10. Iijima, T.; Endo, Y.; Tsuji, M.; Kawachi, E.; Kagechika, H.; Shudo, K. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists. Chem. Pharm. Bull. 1999, 47, 398-404. Endo, Y.; Iijima, T.; Ohta, K.; Kagechika, H.; Kawachi, E.; Shudo, K Dicarba-closo-dodecaboranes as a Pharmacophore. Nonel Potent Retinoidal Agonists. Chem. Pharm. Bull. 1999, 47, 585-587.
11. Dodds, E. C.; Goldberg, L.; Lawson, W.; Robinson, R. Estrogenic activity of alkylated stilbestrol. Nature 1938, 142, 34.
12. Ray, S.; Dwivedy, I. Development of estrogen antagonists as pharmaceutical agents. In Advances in Drug Research; Testa, B., Meyer, U. A., Eds.; Academic Press: San Diego, 1997; Vol. 29, pp 171-270.
13. Miksicek, R. J. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 1993, 44, 37-43.
14. Stone, R. Environmental estrogens stir debate. Science 1994, 265, 308-310.
15. Coult, R.; Fox, M. A.; Gill, W. R.; Herbertson, P. L.; MacBride, J. A. H.; Wade, K C-Arylation and C-heteroarylation of icosahedral carboranes via their copper(I) derivatives. J. Organomet. Chem. 1993, 462, 19-29. Fox, M. A.; MacBride, J. A. H.; Peace, R. J.; Wade, K. Transmission of electronic effects by icosahedral carboranes; skeletal carbon-13-chemical shifts and ultraviolet-visible spectra of substituted aryl-p-carboranes (1,12-dicarba-closo-dodecaboranes). J. Chem. Soc., Dalton Trans. 1998, 401-411.
16. Coult, R.; Fox, M. A.; Gill, W. R.; Herbertson, P. L.; MacBride, J. A. H.; Wade, K C-Arylation and C-heteroarylation of icosahedral carboranes via their copper(I) derivatives. J. Organomet. Chem. 1993, 462, 19-29. Fox, M. A.; MacBride, J. A. H.; Peace, R. J.; Wade, K. Transmission of electronic effects by icosahedral carboranes; skeletal carbon-13-chemical shifts and ultraviolet-visible spectra of substituted aryl-p-carboranes (1,12-dicarba-closo-dodecaboranes). J. Chem. Soc., Dalton Trans. 1998, 401-411.
17. Kahl, S. B.; Kasar, R. A. Simple, high-yield synthesis of polyhedral carborane amino acids. J. Am. Chem. Soc. 1996, 118, 1223-1224.
18. Meyer, T.; Koop, R.; von Angerer, E.; Schonenberger, H.; Holler, E. A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J. Cancer Res. Clin. Oncol. 1994, 120, 359-364.
19. Koike, S.; Sakai, M.; Muramatsu, M. Molecular cloning and characterization of rat estrogen cDNA. Nucleic Acids Res. 1987, 15, 2499-2513.
20. -8 M when 17β-estradiol was used in this assay.
21. Brzozowski, A. M.; Pike, A. C. W.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J.; Carlquist, M. Nature 1997, 389, 753-758. Tanenbaum, D. M.; Wang, Y.; Williams, S. P.; Sigler, P. B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 5998-6003.
22. Brzozowski, A. M.; Pike, A. C. W.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J.; Carlquist, M. Nature 1997, 389, 753-758. Tanenbaum, D. M.; Wang, Y.; Williams, S. P.; Sigler, P. B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 5998-6003.
23. 2-guided region selection approach. J. Med. Chem. 1998, 41, 2261-2267.
24. The relatively high activity of 4-(1-adamantyl)phenol (11) also suggests that the hydrophobic contact along the spherical shape produces a stronger interaction than that in the case of other alkylphenols.